nisoldipine has been researched along with Disease Exacerbation in 4 studies
Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The NICOLE study (NIsoldipine in COronary artery disease in LEuven) is a single centre, randomised, double blind, placebo controlled trial with coronary angiography at baseline, six months, and three years of follow up." | 5.10 | Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study. ( Coussement, P; De Scheerder, IK; Dens, JA; Desmet, WJ; Kerdsinchai, P; Kostopoulos, K; Piessens, JH; Supanantaroek, C, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ruggenenti, P | 1 |
| Cravedi, P | 1 |
| Remuzzi, G | 1 |
| Dens, JA | 2 |
| Desmet, WJ | 2 |
| Coussement, P | 2 |
| De Scheerder, IK | 2 |
| Kostopoulos, K | 2 |
| Kerdsinchai, P | 2 |
| Supanantaroek, C | 2 |
| Piessens, JH | 2 |
| Schrier, RW | 1 |
| Estacio, RO | 1 |
| Esler, A | 1 |
| Mehler, P | 1 |
1 review available for nisoldipine and Disease Exacerbation
| Article | Year |
|---|---|
The RAAS in the pathogenesis and treatment of diabetic nephropathy.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti | 2010 |
3 trials available for nisoldipine and Disease Exacerbation
| Article | Year |
|---|---|
Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study.
Topics: Calcium Channel Blockers; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Disease | 2003 |
Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in LEuven.
Topics: Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Coronary Angiography; Coronary Disease; De | 2001 |
Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diabetes | 2002 |